Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases
暂无分享,去创建一个
Francisco Javier Ruiz-Ojeda | J. Plaza-Díaz | Julio Plaza-Díaz | Angel Gil | Á. Gil | Laura Maria Vilchez-Padial | F. Ruiz-Ojeda | Laura María Vilchez-Padial
[1] D. Aust,et al. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. , 2012, Journal of Crohn's & colitis.
[2] R. Dorfman,et al. Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice , 2016, Experimental and therapeutic medicine.
[3] Zhongjian Chen,et al. Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells. , 2016, Veterinary immunology and immunopathology.
[4] Á. Gil,et al. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. , 2014, The British journal of nutrition.
[5] C. Langner,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.
[6] L. Morelli,et al. FAO Technical meeting on prebiotics. , 2008, Journal of clinical gastroenterology.
[7] F. Romero,et al. Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation , 2013, PloS one.
[8] Y. Ringel,et al. Alterations in the intestinal microbiota and functional bowel symptoms. , 2009, Gastrointestinal endoscopy clinics of North America.
[9] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[10] Adolfo Suárez,et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. , 2014, World journal of gastroenterology.
[11] J. Macfie,et al. Impact of probiotics on colonic microflora in patients with colitis: a prospective double blind randomised crossover study. , 2013, International journal of surgery.
[12] J. Leblanc,et al. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. , 2014, World journal of gastroenterology.
[13] P. O’Toole,et al. Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota , 2008, Interdisciplinary perspectives on infectious diseases.
[14] Yue-jiao Shi,et al. Study on the effects of microencapsulated Lactobacillus delbrueckii on the mouse intestinal flora , 2015, Journal of microencapsulation.
[15] Xia Yang 杨 霞,et al. Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis , 2013, Journal of Huazhong University of Science and Technology [Medical Sciences].
[16] A. Kraneveld,et al. Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis. , 2016, Beneficial microbes.
[17] G R Gibson,et al. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.
[18] A. Hart,et al. Dysregulated Circulating Dendritic Cell Function in Ulcerative Colitis Is Partially Restored by Probiotic Strain Lactobacillus casei Shirota , 2013, Mediators of inflammation.
[19] F. Abadía-Molina,et al. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains , 2017, Scientific Reports.
[20] D. Werling,et al. Effects of Ex-Vivo and In-Vivo Treatment with Probiotics on the Inflammasome in Dogs with Chronic Enteropathy , 2015, PloS one.
[21] D. Raoult,et al. Lactobacillus rhamnosus bacteremia: an emerging clinical entity , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[22] A. Margolles,et al. Association of Levels of Antibodies from Patients with Inflammatory Bowel Disease with Extracellular Proteins of Food and Probiotic Bacteria , 2014, BioMed research international.
[23] M. Geier,et al. Effects of a Lactobacillus reuteri BR11 Mutant Deficient in the Cystine-Transport System in a Rat Model of Inflammatory Bowel Disease , 2012, Digestive Diseases and Sciences.
[24] H. Rafa,et al. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis , 2013, Immunopharmacology and immunotoxicology.
[25] M. Roberfroid. Prebiotics and probiotics: are they functional foods? , 2000, The American journal of clinical nutrition.
[26] G. Rossolini,et al. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature , 2015, Infection.
[27] J M T Hamilton-Miller,et al. Some insights into the derivation and early uses of the word ‘probiotic’ , 2003, British Journal of Nutrition.
[28] H. Nakase,et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial , 2016, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[29] M. Roberfroid. Prebiotics and probiotics: are they functional foods? , 2000, The American journal of clinical nutrition.
[30] M. Geier,et al. Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage , 2012, Supportive Care in Cancer.
[31] T. Churchill,et al. VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury. , 2013, Beneficial microbes.
[32] Tadao Saito,et al. Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced inflammatory response in porcine intestinal epitheliocytes via Toll-like receptor-2 and 4. , 2014, Molecular nutrition & food research.
[33] S. Salminen,et al. Probiotics: an overview of beneficial effects , 2002, Antonie van Leeuwenhoek.
[34] A. Bitton,et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[35] C. Dai,et al. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis , 2012, Molecular and Cellular Biochemistry.
[36] K. Whelan,et al. Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials , 2014, Inflammatory bowel diseases.
[37] Á. Gil,et al. Pyrosequencing Analysis Reveals Changes in Intestinal Microbiota of Healthy Adults Who Received a Daily Dose of Immunomodulatory Probiotic Strains , 2015, Nutrients.
[38] S. Vermeire,et al. Butyricicoccus pullicaecorum in inflammatory bowel disease , 2012, Gut.
[39] I. Elmadfa,et al. Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. , 2012, Beneficial microbes.
[40] Á. Gil,et al. Probiotic Mechanisms of Action , 2012, Annals of Nutrition and Metabolism.
[41] C. Gómez-Llorente,et al. International Immunonutrition Workshop Session 5 : Early programming of the immune system and the role of nutrition Role of Toll-like receptors in the development of immunotolerance mediated by probiotics , 2010 .
[42] J. Galmiche,et al. Saccharomyces boulardii does not prevent relapse of Crohn's disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[43] C. S. Satish Kumar,et al. Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. , 2015, International immunopharmacology.
[44] Elaheh Vahabnezhad,et al. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. , 2013, Journal of clinical gastroenterology.
[45] Elie. Metchnikoff. The Prolongation of Life: Optimistic Studies , 2003 .
[46] R. Lechler,et al. Modulation of dendritic cell phenotype and functionin an in vitro model of the intestinal epithelium , 2006, European journal of immunology.
[47] T. R. Desai,et al. Probiotics: A Review , 2012 .
[48] S. Ng,et al. Human Gut Dendritic Cells Drive Aberrant Gut-specific T-cell Responses in Ulcerative Colitis, Characterized by Increased IL-4 Production and Loss of IL-22 and IFN&ggr; , 2014, Inflammatory bowel diseases.
[49] M. Comalada,et al. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. , 2011, Biochemical pharmacology.
[50] Takuya Suzuki,et al. Modulatory activity of Lactobacillus rhamnosus OLL2838 in a mouse model of intestinal immunopathology. , 2015, Immunobiology.
[51] F. Romero,et al. Human Intestinal Dendritic Cells Decrease Cytokine Release against Salmonella Infection in the Presence of Lactobacillus paracasei upon TLR Activation , 2012, PloS one.
[52] S. Fiorucci,et al. Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3 , 2015, Inflammatory bowel diseases.
[53] Á. Gil,et al. Sources, isolation, characterisation and evaluation of probiotics , 2013, British Journal of Nutrition.
[54] D. Werling,et al. A Prospective, Randomized, Blinded, Placebo‐Controlled Pilot Study on the Effect of Enterococcus faecium on Clinical Activity and Intestinal Gene Expression in Canine Food‐Responsive Chronic Enteropathy , 2015, Journal of veterinary internal medicine.
[55] Namita Singh,et al. Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis , 2015, Journal of pediatric gastroenterology and nutrition.
[56] J. Söderholm,et al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[57] F. Abadía-Molina,et al. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats , 2014, PloS one.
[58] A. Krag,et al. Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial , 2013, Inflammatory bowel diseases.
[59] H. Rafa,et al. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics , 2012, Immunopharmacology and immunotoxicology.
[60] M. Kamm,et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial , 2017, The Lancet.
[61] G. Gloor,et al. Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. , 2014, Journal of Crohn's & colitis.
[62] D. Corella,et al. Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study , 2013, PloS one.
[63] Yasuo Suzuki,et al. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. , 2015, World journal of gastroenterology.
[64] A. Petersen,et al. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. , 2014, Journal of Crohn's & colitis.
[65] A. Bomba,et al. Co-administration of a probiotic strain Lactobacillus plantarum LS/07 CCM7766 with prebiotic inulin alleviates the intestinal inflammation in rats exposed to N,N-dimethylhydrazine. , 2015, International immunopharmacology.
[66] G. Hwang,et al. 1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model , 2010, Archives of pharmacal research.
[67] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[68] F. Hoentjen,et al. Probiotics and prebiotics in ulcerative colitis. , 2016, Best practice & research. Clinical gastroenterology.
[69] J. Plaza-Díaz,et al. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials , 2016, International journal of molecular sciences.
[70] S. Salminen,et al. The impact of probiotic on gut health. , 2009, Current drug metabolism.
[71] Yinglin Xia,et al. Vitamin D receptor pathway is required for probiotic protection in colitis. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[72] C. Cho,et al. Protective effects of cathelicidin‐encoding Lactococcus lactis in murine ulcerative colitis , 2012, Journal of gastroenterology and hepatology.
[73] Glenn R. Gibson,et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .
[74] T. Dinan,et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut , 2013, Gut microbes.
[75] Xiaowei Liu,et al. Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice , 2016, PloS one.